SNC-80
CAS No. 156727-74-1
SNC-80( NIH-10815 )
Catalog No. M12237 CAS No. 156727-74-1
A highly selective, non-peptide agonist of the δ-opioid receptor (δ-OR) with IC50/Ki of 2.73/0.18 nM; displays >2,000-fold selectivity over the μ-opioid receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 32 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 219 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSNC-80
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly selective, non-peptide agonist of the δ-opioid receptor (δ-OR) with IC50/Ki of 2.73/0.18 nM; displays >2,000-fold selectivity over the μ-opioid receptor.
-
DescriptionA highly selective, non-peptide agonist of the δ-opioid receptor (δ-OR) with IC50/Ki of 2.73/0.18 nM; displays >2,000-fold selectivity over the μ-opioid receptor; selectively activates μ-δ heteromers to produce maximal antinociception.Pain Discontinued.
-
In VitroSNC80 selectively activates μ-δ heteromer in HEK293 cells with an EC50 of 52.8 nM. SNC80 exhibits substantially greater activity in cells coexpressing μ- and δ-opioid receptors than in cells either singly expressing δ-opioid receptors or coexpressing δ- and κ-opioid receptors.
-
In VivoSNC80 (10 mg/kg; intraperitoneal injection; once; C57BL6/J mice) treatment significantly attenuated this allodynia caused by overuse of Sumatriptan. Animal Model:Male and female C57BL6/J mice (20-30g) injected with Sumatriptan Dosage:10 mg/kg Administration:Intraperitoneal injection; once Result:Significantly attenuated allodynia.
-
SynonymsNIH-10815
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
RecptorOpioid Receptor
-
Research AreaNeurological Disease
-
IndicationPain
Chemical Information
-
CAS Number156727-74-1
-
Formula Weight449.6
-
Molecular FormulaC28H39N3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (74.13 mM)
-
SMILESO=C(N(CC)CC)C1=CC=C([C@@H](N2[C@@H](C)CN(CC=C)[C@H](C)C2)C3=CC=CC(OC)=C3)C=C1
-
Chemical Name4-[(R)-[(2S,5R)-2,5-dimethyl-4-(2-propen-1-yl)-1-piperazinyl](3-methoxyphenyl)methyl]-N,N-diethyl-benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Calderon SN, et al. J Med Chem. 1994 Jul 8;37(14):2125-8.
2. Bilsky EJ, et al. J Pharmacol Exp Ther. 1995 Apr;273(1):359-66.
3. Metcalf MD, et al. ACS Chem Neurosci. 2012 Jul 18;3(7):505-9.
molnova catalog
related products
-
Calenduloside E
Calenduloside E exhibits hypoglycemic activities by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intestine in oral glucose-loaded rats.
-
Dynorphin B (1-13)
Dynorphin B (1-13) acts as an agonist on opioid κ-receptor.
-
β-Casomorphin, bovin...
β-Casomorphin, bovine TFA is an opioid peptide isolated from casein peptoneβ-Casomorphin, bovine(beta-casomorphin-7) may contribute significantly to mucin production via a direct effect on intestinal goblet cells and the activation of mu-opioid receptors.?
Cart
sales@molnova.com